Sector:
Healthcare

Location:
Bedford, MA

Year Funded:
1997

Status:
IPO

Summary:
NitroMed was the maker of BiDil (isosorbide dinitrate/hydralazine hydrochloride), an orally administered medicine available in the United States for the treatment of heart failure in self-identified black patients.